APA aipamena

Aichler, M., Motschmann, M., Jütting, U., Luber, B., Becker, K., Ott, K., . . . Walch, A. (2014). Epidermal growth factor receptor (EGFR) is an independent adverse prognostic factor in esophageal adenocarcinoma patients treated with cisplatin-based neoadjuvant chemotherapy. Impact Journals LLC.

Chicago Style aipamena

Aichler, Michaela, et al. Epidermal Growth Factor Receptor (EGFR) Is an Independent Adverse Prognostic Factor in Esophageal Adenocarcinoma Patients Treated With Cisplatin-based Neoadjuvant Chemotherapy. Impact Journals LLC, 2014.

MLA aipamena

Aichler, Michaela, et al. Epidermal Growth Factor Receptor (EGFR) Is an Independent Adverse Prognostic Factor in Esophageal Adenocarcinoma Patients Treated With Cisplatin-based Neoadjuvant Chemotherapy. Impact Journals LLC, 2014.